Covance Inc (CVD) financial statements (2020 and earlier)

Company profile

Business Address 210 CARNEGIE CENTER
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
TTM
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 729493
Cash and cash equivalents 618493
Short-term investments 111 
Receivables 332340
Inventory, net of allowances, customer advances and progress billings 4849
Inventory 4849
Prepaid expense and other current assets168
Income taxes receivable 4
Deferred tax assets 5245
Other undisclosed current assets 343137
Total current assets: 1,5041,235
Noncurrent Assets
Property, plant and equipment 914891
Intangible assets, net (including goodwill) 118119
Goodwill 110110
Intangible assets, net (excluding goodwill) 89
Other noncurrent assets 29
Prepaid expense and other noncurrent assets52
Assets held-for-sale, long lived7 
Deferred tax assets, net (32)(28)
Other undisclosed noncurrent assets 1819
Total noncurrent assets: 1,0531,054
TOTAL ASSETS: 2,5572,288
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 238179
Accounts payable 6034
Employee-related liabilities 171145
Taxes payable 8 
Debt  320
Other liabilities 154128
Other undisclosed current liabilities 240256
Total current liabilities: 633883
Noncurrent Liabilities
Long-term debt and lease obligation 250 
Long-term debt, excluding current maturities 250 
Liabilities, other than long-term debt 148143
Deferred tax liabilities, net 7173
Other liabilities 7771
Other undisclosed noncurrent liabilities (39)(45)
Total noncurrent liabilities: 35999
Total liabilities: 991981
Stockholders' equity
Stockholders' equity attributable to parent 1,5651,307
Common stock 11
Treasury stock, value (1,101)(1,067)
Additional paid in capital 860744
Accumulated other comprehensive income 2629
Retained earnings 1,7801,601
Total stockholders' equity: 1,5651,307
TOTAL LIABILITIES AND EQUITY: 2,5572,288

Income statement (P&L) ($ in millions)

9/30/2014
TTM
12/31/2013
12/31/2012
Revenues 2,5952,366
Cost of revenue (2,371)(2,211)
Gross profit: 224155
Operating expenses (7)(39)
Operating income: 217116
Nonoperating income (expense) 10(11)
Investment income, nonoperating 32
Foreign currency transaction loss, before tax (2)(1)
Interest and debt expense (7)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes 76
Income from continuing operations before equity method investments, income taxes: 228105
Income from equity method investments  0
Income from continuing operations before income taxes: 228105
Income tax expense (49)(10)
Net income available to common stockholders, diluted: 17995

Comprehensive Income ($ in millions)

9/30/2014
TTM
12/31/2013
12/31/2012
Net income: 17995
Comprehensive income: 17995
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (3)24
Comprehensive income, net of tax, attributable to parent: 176119

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: